Cancer Research
Degarelix vs Goserelin Head-to-Head in Advanced Prostate Cancer
Phase 3 trial pits next-gen GnRH antagonist degarelix against standard goserelin in prostate cancer hormone suppression.
Clinical Trial
Jul 2, 2026 0
Cancer
86 articles in this topic
Cancer Research
Abraxane Plus Pembrolizumab Targets Advanced Bladder Cancer in Cisplatin-Ineligible Patients
A completed phase 2 trial tested nab-paclitaxel combined with the checkpoint inhibitor pembrolizumab in patients with advanced urothelial cancer who cannot tolerate cisplatin.
Clinical Trial
Jul 1, 2026 0
Cancer Research
Low-Dose Gut Radiation Revives Immune Checkpoint Therapy in Drug-Resistant Cancers
A phase II trial tests whether 1Gy intestinal radiation can re-sensitize solid tumors that have stopped responding to immunotherapy.
Clinical Trial
Jul 1, 2026 0
Cancer Research
Bevacizumab Added to Chemo Tested in Children With Metastatic Sarcoma
A Phase 2 trial examines whether adding the anti-angiogenic drug bevacizumab to standard chemo improves outcomes in pediatric sarcoma.
Clinical Trial
Jun 30, 2026 0
Cancer Research
Triple Combo Targets Chemotherapy-Resistant Pancreatic Cancer With Immune Boost
A phase I trial tests SD-101, nivolumab, and radiation together against metastatic pancreatic cancer that has stopped responding to chemo.
Clinical Trial
Jun 29, 2026 0
Cancer Research
Personalized Neoantigen Vaccine Targets Hard-to-Treat Solid Tumors
A Phase 1/2 trial tests a custom cancer vaccine paired with checkpoint inhibitors in patients with advanced solid tumors.
Clinical Trial
Jun 28, 2026 0
Cancer Research
Brentuximab Vedotin Beats Standard Chemo as Frontline Hodgkin Lymphoma Treatment
A completed phase 3 trial compared A+AVD versus ABVD for advanced classical Hodgkin lymphoma, testing whether replacing bleomycin with brentuximab vedotin improves outcomes.
Clinical Trial
Jun 26, 2026 0
Cancer Research
Pfizer Tests BCMA Bispecific Antibody Elranatamab in Relapsed Multiple Myeloma
Phase 1 trial evaluates PF-06863135 (elranatamab) alone and with immunomodulatory agents to find safe dosing in heavily pretreated myeloma patients.
Clinical Trial
Jun 24, 2026 0
Cancer Research
MD Anderson Tests Dual Checkpoint Blockade Plus Radiation for HPV Throat Cancer
A phase II trial explored ipilimumab, nivolumab, and radiation therapy in advanced HPV-positive oropharyngeal cancer — but was terminated early.
Clinical Trial
Jun 20, 2026 0
Cancer Research
Poxvirus Cancer Vaccines Targeting CEA and MUC-1 Tested in Advanced Solid Tumors
A Phase 1/2 NCI trial tested PANVAC vaccinia and fowlpox vaccines plus immune booster sargramostim in advanced colorectal, breast, and ovarian cancers.
Clinical Trial
Jun 18, 2026 0
Cancer Research
12-Week Exercise Program Targets Body Composition in Breast Cancer Survivors
A completed trial examines how structured exercise reshapes body composition and sustains physical activity habits in breast cancer patients post-diagnosis.
Clinical Trial
Jun 17, 2026 0
Cancer Research
Spinal Delivery of Rituximab Tested for Brain and Spine Lymphoma Involvement
MD Anderson's Phase 1/2 trial explored injecting rituximab directly into spinal fluid to target CNS lymphoid malignancies.
Clinical Trial
Jun 16, 2026 0
Page 1 of 8Next